Table 1.

Patient demographics and perioperative outcomes in patients with normal and decreased LiMAx value who underwent minor or major minimally invasive liver surgery (MILS).

		Normal LiMAx Value (>315 µg/h/kg) n (% or SD)	Decreased LiMAx Value (≤315 µg/h/kg) n (% or SD)	p-Value	Total n (% or SD)
Total		22 (55.0)	18 (45.0)		40 (100.0)
Sex	male	12 (54.5)	13 (72.2)	0.332	25 (62.5)
	female	10 (45.5)	5 (27.8)		15 (37.5)
Age; years		64.0 (12.0)	70.6 (7.2)	0.058	66.9 (10.5)
BMI; kg/m2		25.9 (4.0)	30.4 (5.2)	0.005	27.9 (5.0)
LiMAx value; µg/h/kg		466.2 (114.8)	234.9 (56.8)	<0.001	362.1 (148.6)
Liver cirrhosis		2 (9.1)	10 (55.6)	0.002	12 (30.0)
Liver cirrhosis	None	20 (90.9)	8 (44.4)	0.005	28 (70.0)
	Child A	2 (9.1)	8 (44.4)		10 (25.0)
	Child B	0 (0.0)	2 (11.1)		2 (5.0)
Operation time; min		356.6 (148.6)	228.1 (107.2)	0.003	298.8 (145.2)
IBL; mL		495.5 (470.0)	380.6 (352.8)	0.459	443.8 (420.2)
Intraoperative blood transfusion		8 (36.4)	1 (5.6)	0.027	9 (22.5)
LOS; days		15.6 (14.2)	11.5 (9.8)	0.338	13.8 (12.4)
Liver surgery related morbidity		4 (18.2)	1 (5.6)	0.355	5 (12.5)
30-day mortality		1 (4.6)	0 (0.0)	1.000	1 (2.5)
Operation technique	laparoscopic	4 (18.2)	12 (66.7)	0.003	16 (40.0)
	robotic	18 (81.8)	6 (33.3)		24 (60.0)
Extent of resection	major	13 (59.1)	2 (11.1)	0.003	15 (37.5)
	minor	9 (40.9)	16 (88.9)		25 (62.5)
Previous abdominal surgery		13 (59.1)	8 (44.4)	0.525	21 (52.5)
Tumor dignity	malignant	18 (81.8)	16 (88.9)	0.673	34 (85.0)
	benign	4 (18.2)	2 (11.1)		6 (15.0)
R status in malignant cases	R0	17 (94.4)	14 (87.5)	0.591	31 (91.2)
	R1	1 (5.6)	2 (12.5)		3 (8.8)

BMI = body mass index, IBL = intraoperative blood loss, LOS = length of stay, SD = standard deviation. Significant values (p < 0.05) marked in bold.